Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

NCT00749684 · clinicaltrials.gov ↗

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Interferon α-2b

Sponsor

Merck Sharp & Dohme LLC